Home › Valeant Pharmaceuticals Intl Inc (VRX) Receives Underperform Rating from Wells Fargo
 

Keywords :   


Valeant Pharmaceuticals Intl Inc (VRX) Receives Underperform Rating from Wells Fargo

2016-04-15 22:46:50| Biotech - Topix.net

's stock had its "underperform" rating restated by research analysts at Wells Fargo in a report issued on Friday, MarketBeat.com reports. Shares of Valeant Pharmaceuticals Intl traded down 0.03% during midday trading on Friday, reaching $32.35.

Tags: rating receives wells intl

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
16.05Croda Beauty Launches New Ceramide Range
16.05Doves New Bond Strength Range Contains Proprietary Bio-Protein Care and Peptides
16.05Mount Sinai Awarded $6.6 Million from National Institutes of Health to Investigate Treatment ...
16.05Eastern North Pacific Tropical Weather Outlook
16.05Amherst Label adds third Domino press
16.05Atlantic Tropical Weather Outlook
16.05Simply.TV provides metadata to Drei TV Austria
16.05Backlash as Morrisons trials sale of New Zealand lamb
More »